Labcyte to Merge with Deerac Fluidics | GenomeWeb
NEW YORK (GenomeWeb News) – Labcyte and Allegro Technologies, which conducts business as Deerac Fluidics, have agreed to merge, the companies said Sunday.
 
Financial terms of the deal were not disclosed.
 
Labcyte offers a droplet ejection technology that is used in compound management, assays, arraying, particle manufacturing, imaging mass spectrometry, and live cell transfer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.